TransMedics Group Inc Cash Flow-to-Debt Ratio

Latest as of June 2026: 0.02x

TransMedics Group Inc cash flow-to-debt ratio. TransMedics Group Inc (TMDX) has a Cash Flow-to-Debt Ratio of 0.02x as of June 2026, meaning its operating cash flow of $17.31 Million could theoretically repay 0% of its total liabilities ($946.34 Million) in one year. Check TransMedics Group Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

CF-to-Debt Ratio

0.02x
Operating CF / Total Liabilities

Operating Cash Flow

$17.31 Million
USD

Total Liabilities

$946.34 Million
USD

Data as of

Jun 2026
Most recent filing

Cash Flow-to-Debt Ratio of TransMedics Group Inc (2006–2025)

Cash flow-to-debt ratio of TransMedics Group Inc from 2006 to 2025. Historical debt coverage capacity for TransMedics Group Inc across 11 annual periods. Check cash flow quality index of TransMedics Group Inc to evaluate the quality of earnings relative to operating cash generation.

TransMedics Group Inc Cash Flow-to-Debt Ratio by Year (2006–2025)

TransMedics Group Inc cash flow-to-debt ratio by year from 2006 to 2025. Year-by-year debt coverage analysis for TransMedics Group Inc. For the full cash flow conversion analysis, see cash efficiency ratio of TransMedics Group Inc.

Year CF-to-Debt Ratio Operating CF (USD) Total Liabilities YoY Change
2025 0.32x $192.84 Million $595.27 Million ▲ +282.0%
2024 0.08x $48.80 Million $575.47 Million ▲ +470.3%
2023 -0.02x $-13.03 Million $568.85 Million ▲ +95.5%
2022 -0.51x $-45.82 Million $89.77 Million ▼ -18.5%
2021 -0.43x $-28.86 Million $67.04 Million ▲ +31.5%
2020 -0.63x $-30.27 Million $48.13 Million ▲ +1.4%
2019 -0.64x $-32.29 Million $50.65 Million ▼ -15.3%
2018 -0.55x $-25.98 Million $46.98 Million ▼ -392.6%
2017 -0.11x $-23.10 Million $205.72 Million ▲ +91.0%
2016 -1.25x $-24.11 Million $19.32 Million ▲ +53.2%
2006 -2.67x $-16.27 Million $6.10 Million —
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.